NEW YORK (GenomeWeb) – Thermo Fisher Scientific said this week it has signed a definitive agreement to sell its Cole-Parmer channel business to private equity firm GTCR for $480 million in cash. Cole-Parmer, part of Thermo Fisher's Laboratory Products and Services segment, provides fluid handling, test and measurement, and electrochemistry products and services. It has 400 employees worldwide and recorded $230 million in revenues last year. The deal is expected to close in the third quarter and is anticipated to have no material impact on Thermo Fisher's adjusted EPS.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.